Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Global Forecasts to 2017

Publisher Name :
Date: 3-Apr-2013
No. of pages: 368
Inquire Before Buying

The global injectable drug delivery technologies market was valued at $22.5 billion in 2012, and is expected to reach $43.3 billion by 2017 at a CAGR of 14.0% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The global injectable drug delivery formulations technologies market was the largest segment in this market. This is due to surge of biologics and development of nanotechnologies. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.

The growth of the injectable drug delivery technologies market is primarily triggered by product life cycle management, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes at global level and improving patient compliance. The evolving opportunities in this market for manufacturers include development of biosimilars in pharmaceutical markets and focus of pharmaceutical manufacturers towards emerging markets such as, India, and China. However, factors such as needle-stick injuries and infections, development of alternate delivery methods and product recalls are restraining the growth of the market.

North America accounted for the largest market share of 41.3% of the global injectable drug delivery technologies market, followed by Europe (30.2%) in 2012. However, the region lags behind Europe in the self injection devices market. This is owing to low penetration rate of pen injectors in the U.S. Asian and Latin American countries represent the fastest growing markets due to growing number of cancer and diabetes incidences, and improving patent compliance. Furthermore, stringent regulatory policies for approval of medical devices, and high competition in mature countries will compel the companies to focus on the emerging markets in Latin America and Asia.

Scope of the Report

This research report categorizes the global injectable drug delivery technologies marketinto two segments, namely, global injectable drug delivery devices technologies and global injectable drug delivery formulations technologies. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography (North America, Europe, Asia-Pacific, and Rest of the World) to provide in-depth information on the global scenario.

Global Injectable Drug Delivery Technologies Market, By Segment

  • Injectable Drug Delivery Devices Technologies
  • Injectable Drug Delivery Formulations Technologies

Global Injectable Drug Delivery Devices TechnologiesMarket, By Product

Conventional Injection Devices

By Material

  • Glass
  • Plastics

By Product

  • Fillable Syringes
  • Prefilled Syringes

By Usability

  • Reusable
  • Disposable

Self-Injection Devices

Needle Free Injectors

By Product

  • Fillable Syringes
  • Prefilled Syringes

By Technology

  • Jet Based Needle Free Injectors
  • Spring Based Needle Free Injectors
  • Laser Powered Needle Free Injectors
  • Others

By Usability

  • Reusable
  • Disposable

Auto Injectors

By Products

  • Fillable Syringes
  • Prefilled Syringes

By Technology

  • Manual Injection Auto Injectors
  • Automated Injection Auto Injectors

By Design

  • Standardized Auto Injectors
  • Customized Auto Injectors

By Usability

  • Reusable
  • Disposable

Pen Injectors

By Products

  • Single Chambered Pen Injectors
  • Dual Chambered Pen Injectors

By design

  • Standardized pen injectors
  • Customized pen injectors

By usability

  • Reusable
  • Disposable
  • Others

Global Injectable Drug Delivery Formulations TechnologiesMarket, By Product

Conventional Drug Delivery Formulations

  • Solution
  • Reconstituted / Lyophilized Formulations

Novel Drug Delivery Formulations

  • Liposomal Systems
  • Microspheres
  • Nanoparticles
  • Polymeric Micelles
  • Others

Global Injectable Drug Delivery TechnologiesMarket, By TherapeuticApplications

Auto Immune Diseases

  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Crohn’s Diseases
  • Psoriasis
  • Others

Hormonal Disorders

  • Diabetes
  • Antithrombotic / Thrombolytic Therapy
  • Reproductive Health Diseases
  • Anemia
  • Osteoporosis
  • Others
  • Orphan Diseases
  • Oncology
  • Others

Pain Management

  • Allergies
  • Hepatitis C
  • Aesthetic Treatment

Injectable Drug Delivery Technologies Market, By Geography

  • North America
  • Europe
  • Asia-Pacific
  • RoW

Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Global Forecasts to 2017

Table Of Contents

1 Introduction 27
1.1 Key Take-Aways 27
1.2 Report Description 27
1.3 Markets Covered 29
1.4 Stakeholders 32
1.5 Research Methodology 32
1.5.1 Market Size 32
1.5.2 Market Share 33
1.5.3 Key Data Points From Secondary Sources 33
1.5.4 Key Data Points From Primary Sources 33
1.5.5 Assumptions 34

2 Executive Summary 35

3 Market Overview 40
3.1 Introduction 41
3.2 Market Segmentation 45
3.3 Market Dynamics 48
3.3.1 Drivers 49
3.3.1.1 Technological Advancements 49
3.3.1.2 Product Life Cycle Management 49
3.3.1.3 Surge Of Biologics In Pharmaceutical Markets 50
3.3.1.4 Rising Incidences Of Cancer And Diabetes 51
3.3.1.5 Improving Patient Compliance 51
3.3.2 Restraints 52
3.3.2.1 Regulatory Hurdles 52
3.3.2.2 Needle-Stick Injuries And Infections 53
3.3.2.3 Development Of Alternate Delivery Methods 54
3.3.2.4 Product Recalls 55
3.3.3 Opportunities 56
3.3.3.1 Emerging Markets (India, China, Brazil, Mexico And Latin America) 56
3.3.3.2 Development Of Biosimilars In The Pharmaceutical Market 57
3.3.4 Challenges 58
3.3.4.1 Sustainability Of Players In Highly Competitive Market 58
3.4 Market Share Analysis, By Major Players 59
3.4.1 Conventional Injectable Devices 59
3.4.2 Self-Injection Devices 61
3.4.2.1 Needle Free Injectors 62
3.4.2.2 Auto Injectors 64
3.4.2.3 Pen Injectors 66

4 Global Injectable Drug Delivery Devices Technologies Market 68
4.1 Introduction 69
4.2 Market Segmentation 72
4.3 Manufacturers Criteria For Selection Of An Injectable Device 74
4.4 Conventional Injectable Drug Delvery Devices 76
4.4.1 By Usability 78
4.4.1.1 Disposable 79
4.4.1.2 Reusable 80
4.4.2 By Material 82
4.4.2.1 Glass 82
4.4.2.2 Plastic 84
4.4.3 By Product 86
4.4.3.1 Prefilled 87
4.4.3.2 Fillable 88
4.5 Self-Injection Devices 90
4.5.1 Market Segmentation 94
4.5.2 Selection Criteria For Self-Injection Device 95
4.5.3 Pen Injectors 96
4.5.3.1 By Product 98
4.5.3.1.1 Single Chamber Pen Injectors 99
4.5.3.1.2 Dual Chamber Pen Injectors 101
4.5.3.2 By Usability 102
4.5.3.2.1 Disposable Pen Injectors 103
4.5.3.2.2 Reusable Pen Injectors 104
4.5.3.3 By Design 105
4.5.3.3.1 Standard Pen Injectors 106
4.5.3.3.2 Customized Pen Injectors 107
4.5.4 Needle-Free Injectors 108
4.5.4.1 By Product 110
4.5.4.1.1 Prefilled Needle Free Injectors 111
4.5.4.1.2 Fillable Needle Free Injectors 112
4.5.4.2 By Technology 113
4.5.4.2.1 Jet-Based Needle-Free Injectors 114
4.5.4.2.2 Spring-Based Needle-Free Injectors 115
4.5.4.2.3 Laser-Based Needle Free Injectors 117
4.5.4.2.4 Vibration-Based Needle Free Injectors 118
4.5.4.3 By Usability 119
4.5.4.3.1 Disposable 120
4.5.4.3.2 Reusable 121
4.5.5 Auto Injectors 122
4.5.5.1 By Product 124
4.5.5.1.1 Prefilled Auto Injectors 125
4.5.5.1.2 Fillable Auto Injectors 126
4.5.5.2 By Technology 127
4.5.5.2.1 Automated Auto Injectors 128
4.5.5.2.2 Manual Auto Injectors 129
4.5.5.3 By Design 130
4.5.5.3.1 Standardized Auto Injectors 131
4.5.5.3.2 Customized Auto Injectors 132
4.5.5.4 By Usability 134
4.5.5.4.1 Disposable Auto Injectors 135
4.5.5.4.2 Reusable Auto Injectors 136
4.6 Others 138

5 Global Injectable Drug Delivery Formulation Technologies Market 140
5.1 Introduction 141
5.2 Conventional Drug Delivery 143
5.2.1 Injectable Solutions 145
5.2.2 Reconstituted/Lyophilized Formulations 147
5.3 Novel Drug Delivery Formulation Technologies 149
5.3.1 Market Segmentation 152
5.3.2 Liposomal Systems 153
5.3.3 Microspheres 154
5.3.4 Nanoparticles 156
5.3.5 Polymeric Micelles 158
5.3.6 Others 160

6 Global Injectable Drug Delivery Technologies Market, By Therapeutic Applications 163
6.1 Introduction 164
6.2 Auto-Immune Diseases 168
6.2.1 Multiple Sclerosis 171
6.2.2 Rheumatoid Arthritis 172
6.2.3 Crohn's Diseases 174
6.2.4 Psoriasis 176
6.2.5 Others 177
6.3 Hormonal Disorders 179
6.3.1 Diabetes 182
6.3.2 Anemia 184
6.3.3 Reproductive Health Diseases 186
6.3.4 Antithrombotic/Thrombolytic Therapy 187
6.3.5 Osteoporosis 189
6.3.6 GRoWth Hormone Deficiency 190
6.4 Orphan/Rare Diseases 193
6.5 Oncology 195
6.6 Others 197
6.6.1 Pain Management 198
6.6.2 Hepatitis C 200
6.6.3 Allergies 202
6.6.4 Aesthetic Treatment 203

7 Geographic Analysis 206
7.1 Introduction 207
7.1.1 North America Dominates The Market 207
7.2 North America 210
7.2.1 GRoWing Incidences Of Diabetes And Developments In Needle Free Technology Drive The Market 210
7.2.2 Needlestick Injuries Have Been Hindering This Market 213
7.3 Europe 215
7.3.1 Liberalization Of Generics Market And Surge In Biologic Has Been Driving The Market 215
7.3.2 High Presence Of Injectable Drug Delivery Market Leaders Drives The Market 217
7.3.3 Hormonal Disorders Have Been Highly Affecting The Demographics In Europe 218
7.3.4 The Region Has Strict Legislations To Prevent Rising Incidences Of Needlestick Injuries 219
7.4 Asia-Pacific 220
7.4.1 APAC Is The Fastest GRoWing Region For This Market 220
7.4.2 The Region Experiences Rising Focus Of Various Giant Players 222
7.5 RoW 224
7.5.1 Rising Incidences Of Cancer And Diabetes As Well As Adaptive Regulatory Policies Is Driving The Market 224
7.5.2 Adaptive Regulatory Policies In Mexico & Brazil Is Supporting The Market GRoWth 226

8 Competitive Landscape 229
8.1 Introduction 229
8.2 Expansion 232
8.3 Agreements, Partnerships, Collaborations & Joint Ventures 239
8.4 New Product Launch 246
8.5 Mergers & Acquisitions 251
8.6 Other Developments 253
8.7 Approvals 258

9 Company Profiles 260
(Overview, Financials, Products & Services, Strategy, & Developments)*
9.1 Alkermes, Inc. 260
9.2 Antares Pharma, Inc. 266
9.3 Baxter International, Inc. 273
9.4 Becton, Dickinson And Company 279
9.5 Bespak Europe, Ltd. (Subsidiary Of Consort Medical, Plc) 286
9.6 Crossject 291
9.7 Elcam Medical 294
9.8 Eli Lilly And Company 297
9.9 Gerresheimer AG 303
9.10 Haselmeier Gmbh 309
9.11 Injex Pharma Gmbh (Subsidiary Of Hns International, Inc.) 312
9.12 Novo Nordisk A/S 316
9.13 Owen Mumford, Ltd. 322
9.14 Sanofi 325
9.15 Schott Ag 330
9.16 SHL Group 335
9.17 Terumo Corporation 339
9.18 Unilife Corporation 345
9.19 Vetter Pharma-Fertigung Gmbh & Co. Kg 350
9.20 West Pharmaceutical Services, Inc. 353
9.21 Ypsomed Holding Ag 358
9.22 Zogenix, Inc. 365
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.

List Of Tables

Table 1 Global Injection Drug Delivery Technologies Market, By Segment, 2010 – 2017 ($Billion) 37
Table 2 Global Injectable Drug Delivery Technologies Market, By Segment, 2010 – 2017 ($Billion) 42
Table 3 Injection Drug Delivery Technologies Market, By Geography, 2010 – 2017 ($Billion) 44
Table 4 Global Injectable Drug Delivery Devices Technologies Market, By Product, 2010 – 2017 ($Billion) 70
Table 5 Injection Drug Delivery Devices Technologies Market, By Geography, 2010 – 2017 ($Billion) 71
Table 6 Conventional Injection Devices Market, By Geography, 2010 – 2017 ($Billion) 77
Table 7 Global Conventional Injection Devices Market, By Usability, 2010 – 2017 ($Billion) 78
Table 8 Disposable Conventional Devices Market, By Geography, 2010 – 2017 ($Billion) 79
Table 9 Reusable Conventional Devices Market, By Geography, 2010 – 2017 ($Billion) 81
Table 10 Global Conventional Injection Devices Market, By Material, 2010 – 2017 ($Billion) 82
Table 11 Conventional Injection Devices (Glass) Market, By Geography, 2010 – 2017 ($Billion) 83
Table 12 Conventional Injection Devices (Plastic) Market, By Geography, 2010 – 2017 ($Billion) 85
Table 13 Global Conventional Injection Devices Market, By Product, 2010 – 2017 ($Billion) 86
Table 14 Prefilled Conventional Injection Devices Market, By Geography, 2010 – 2017 ($Billion) 87
Table 15 Fillable Conventional Injection Devices Market, By Geography, 2010 – 2017 ($Billion) 88
Table 16 Major Therapeutic Areas For Self-Injection Devices 90
Table 17 Global Self-Injection Devices Market, By Product, 2010 – 2017 ($Billion) 91
Table 18 Self-Injection Devices Market, By Geography, 2010 – 2017 ($Billion) 92
Table 19 Pen Injector Market, By Geography, 2010 – 2017 ($Million) 97
Table 20 Global Pen Injectors Market, By Product, 2010 – 2017 ($Million) 99
Table 21 Single Chamber Pen Injector Market, By Geography, 2010 – 2017 ($Million) 100
Table 22 Dual Chamber Pen Injector Market, By Geography, 2010 – 2017 ($Million) 101
Table 23 Global Pen Injectors Market, By Usability, 2010 – 2017 ($Million) 102
Table 24 Disposable Pen Injectors Market, By Geography, 2010 – 2017 ($Million) 103
Table 25 Reusable Pen Injectors Market, By Geography, 2010 – 2017 ($Million) 104
Table 26 Global Pen Injectors Market, By Design, 2010 – 2017 ($Million) 105
Table 27 Standard Pen Injectors Market, By Geography, 2010 – 2017 ($Million) 106
Table 28 Customized Pen Injectors Market, By Geography, 2010 – 2017 ($Million) 107
Table 29 Needle Free Injectors Market, By Geography, 2010 – 2017 ($Million) 109
Table 30 Global Needle Free Injectors Market, By Product, 2010 – 2017 ($Million) 110
Table 31 Prefilled Needle Free Injectors Market, By Geography, 2010 – 2017 ($Million) 111
Table 32 Fillable Needle Free Injectors Market, By Geography, 2010 – 2017 ($Million) 112
Table 33 Global Needle Free Injectors Market, By Technology, 2010 – 2017 ($Million) 113
Table 34 Jet-Based Needle Free Injector Market, By Geography, 2010 – 2017 ($Million) 115
Table 35 Spring-Based Needle Free Injector Market, By Geography, 2010 – 2017 ($Million) 116
Table 36 Laser-Powered Needle Free Injector Market, By Geography, 2010 – 2017 ($Million) 117
Table 37 Vibration-Based Needle Free Injector Market, By Geography, 2010 – 2017 ($Million) 118
Table 38 Global Needle Free Injectors Market, By Usability, 2010 – 2017 ($Million) 119
Table 39 Disposable Needle Free Injectors Market, By Geography, 2010 – 2017 ($Million) 120
Table 40 Reusable Needle Free Injectors Market, By Geography, 2010 – 2017 ($Million) 121
Table 41 Auto Injectors Products Market, By Geography, 2010 – 2017 ($Million) 123
Table 42 Global Auto Injectors Market, By Product, 2010 – 2017 ($Million) 124
Table 43 Prefilled Auto Injectors Market, By Geography, 2010 – 2017 ($Million) 125
Table 44 Fillable Auto Injectors Market, By Geography, 2010 – 2017 ($Million) 126
Table 45 Global Auto Injectors Market, By Technology, 2010 – 2017 ($Million) 127
Table 46 Automated Auto Injectors Market, By Geography, 2010 – 2017 ($Million) 128
Table 47 Manual Auto Injectors Market, By Geography, 2010 – 2017 ($Million) 129
Table 48 Global Auto Injectors Market, By Design, 2010 – 2017 ($Million) 130
Table 49 Standardized Auto Injectors Market, By Geography, 2010 – 2017 ($Million) 131
Table 50 Customized Auto Injectors Auto Injectors Market, By Geography, 2010 – 2017 ($Million) 133
Table 51 Global Auto Injectors Market, By Usability, 2010 – 2017 ($Million) 134
Table 52 Disposable Auto Injectors Market, By Geography, 2010 – 2017 ($Million) 135
Table 53 Reusable Auto Injectors Market, By Geography, 2010 – 2017 ($Million) 137
Table 54 Others Injectors Market, By Geography, 2010 – 2017 ($Million) 138
Table 55 Global Injectable Drug Delivery Formulation Technologies Market, By Segment, 2010 – 2017 ($Billion) 141
Table 56 Injectable Drug Delivery Formulation Technologies Market, By Geography, 2010 – 2017 ($Billion) 142
Table 57 Global Conventional Drug Delivery Formulation Technologies Market, 2010 – 2017 ($Billion) 144
Table 58 Conventional Drug Delivery Formulation Technologies Market, By Geography, 2010 – 2017 ($Billion) 145
Table 59 Injectable Solutions Conventional Drug Delivery Formulation Market, By Geography, 2010 – 2017 ($Billion) 146
Table 60 Reconstituted/Lyophilized Conventional Drug Delivery Formulation Market, By Geography, 2010 – 2017 ($Billion) 147
Table 61 Novel Drug Delivery Formulation Technologies Market, 2010 – 2017 ($Billion) 149
Table 62 Novel Drug Delivery Formulation Technologies Market, By Geography, 2010 – 2017 ($Billion) 151
Table 63 Liposome Drug Delivey Formulation Market, By Geography, 2010 – 2017 ($Million) 153
Table 64 Microspheres Drug Delivey Formulation Market, By Geography, 2010 – 2017 ($Million) 155
Table 65 Nanoparticles Drug Delivey Formulation Market, By Geography, 2010 – 2017 ($Million) 157
Table 66 Polymeric Micelles Drug Delivey Formulation Market, By Geography, 2010 – 2017 ($Million) 159
Table 67 Others Novel Drug Delivey Formulation Market, By Geography, 2010 – 2017 ($Billion) 161
Table 68 Global Injectable Drug Delivery Technologies Market, By Therapeutic Applications, 2010 – 2017 ($Million) 164
Table 69 Global Auto-Immune Therapeutic Market, By Indication, 2010 – 2017 ($Million) 169
Table 70 Auto-Immune Therapeutic Market, By Geography, 2010 – 2017 ($Million) 170
Table 71 Multiple Sclerosis Market, By Geography, 2010 – 2017 ($Million) 171
Table 72 Rheumatoid Arthritis Market, By Geography, 2010 – 2017 ($Million) 173
Table 73 Crohn's Diseases Market, By Geography, 2010 – 2017 ($Million) 175
Table 74 Psoriasis Market, By Geography, 2010 – 2017 ($Million) 176
Table 75 Other Auto-Immune Diseases Market, By Geography, 2010 – 2017 ($Million) 178
Table 76 Global Hormonal Disorders, By Indication, 2010 – 2017 ($Million) 180
Table 77 Hormonal Disorders Market, By Geography, 2010 – 2017($Billion) 181
Table 78 Diabetes Market, By Geography, 2010 – 2017 ($Billion) 182
Table 79 Anemia Market, By Geography, 2010 – 2017 ($Million) 184
Table 80 Reproductive Health Diseases Market, By Geography, 2010 – 2017($Million) 186
Table 81 Antithrombotic Therapy Market, By Geography, 2010 – 2017 ($Million) 188
Table 82 Osteoporosis Market, By Geography, 2010 – 2017($Million) 189
Table 83 GRoWth Hormone Deficiency Market, By Geography, 2010 – 2017 ($Million) 191
Table 84 Orphan/Rare Diseases Therapeutic Market, By Geography, 2010 – 2017 ($Million) 193
Table 85 Oncology Therapeutic Market, By Geography, 2010 – 2017 ($Million) 195
Table 86 Global Other Therapeutic Market, 2010 – 2017 ($Million) 197
Table 87 Other Therapeutic Market, By Geography, 2010 – 2017 ($Million) 198
Table 88 Pain Management Market, By Geography, 2010 – 2017 ($Million) 199
Table 89 Hepatitis C Market, By Geography, 2010 – 2017 ($Million) 201
Table 90 Allergies/Anaphylytic Shock Market, By Geography, 2010 – 2017 ($Million) 202
Table 91 Aesthetic Treatment Market, By Geography, 2010 – 2017 ($Million) 204
Table 92 North America: Injectable Drug Delivery Technologies Market,2010 – 2017 ($Billion) 211
Table 93 North America: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 – 2017 ($Billion) 212
Table 94 North America: Injectable Drug Delivery Formulation Technologies Market, 2010 – 2017 ($Billion) 213
Table 95 North America: Injectable Drug Delivery Technologies Market, By Therapeutic Application 2010 – 2017 ($Billion) 214
Table 96 Europe: Injectable Drug Delivery Technologies Market, 2010 – 2017 ($Billion) 215
Table 97 Europe: Injectable Drug Delivery Devices Technologies Market, 2010 – 2017 ($Million) 216
Table 98 Europe Injectable Drug Delivery Formulations Technologies Market, By Segment, 2010 – 2017 ($Billion) 217
Table 99 Europe: Injectable Drug Delivery Technologies Market, By Therapeutic Appliction, 2010 – 2017 ($Billion) 218
Table 100 APAC: Injectable Drug Delivery Technologies Market, By Segment,2010 – 2017 ($Billion) 220
Table 101 APAC: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 – 2017 ($Million) 221
Table 102 APAC: Injectable Drug Delivery Formulations Technologies Market, By Segment, 2010 – 2017 ($Billion) 222
Table 103 APAC: Injectable Drug Delivery Technologies Market, By Therapeutic Application, 2010 – 2017 ($Million) 223
Table 104 RoW: Injectable Drug Delivery Technologies Market, By Segment, 2010 – 2017 ($Million) 225
Table 105 RoW: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 – 2017 ($Million) 226
Table 106 RoW: Injectable Drug Delivery Formulations Technologies Market, By Segment, 2010 – 2017 ($Million) 227
Table 107 RoW: Injectable Drug Delivery Technologies Market, By Therapeutic Application, 2010 – 2017 ($Million) 228
Table 108 Expansion, 2010 – 2013 232
Table 109 Agreements, Partnerships, Collaborations & Joint Ventures, 2010 – 2013 239
Table 110 New Product Launch, 2010 – 2013 246
Table 111 Mergers & Acquisitions, 2010 – 2013 251
Table 112 Other Developments, 2010 – 2013 253
Table 113 Approvals, 2010 – 2013 258
Table 114 Alkermes: Total Revenue And R&D Expenses, 2009– 2011 ($Million) 261
Table 115 Alkermes: Total Revenue, By Geography, 2009 – 2011 ($Million) 261
Table 116 Antares Pharma: Total Revenues And R&D Expenditure, 2010 – 2012 ($Million) 267
Table 117 Antares Pharma: Total Revenue, By Geography, 2010 – 2012 ($Million) 267
Table 118 Antares Pharma: Total Revenue, By Product, 2010 – 2012 ($Million) 268
Table 119 Baxter International: Total Revenue And R&D Expenses, 2010 – 2012 ($Million) 274
Table 120 Baxter International: Total Revenue, By Segment, 2010 – 2012 ($Million) 274
Table 121 Baxter International: Medical Products Total Revenue, 2010 – 2012($Million) 275
Table 122 Baxter International: Total Revenue, By Geography, 2010 – 2012 ($Million) 276
Table 123 Becton Dickinson: Total Revenues & R&D Expenditure, 2010 – 2012 ($Million) 280
Table 124 Becton Dickinson: Total Revenue, By Segment, 2010 – 2012 ($Million) 280
Table 125 Becton Dickinson: Medical Division Total Revenue, 2010 – 2012 ($Million) 281
Table 126 Becton Dickinson: Total Revenue, By Geography, 2010– 2012 ($Million) 281
Table 127 Consort Medical: Total Revenue And R&D Expense, 2009 – 2011 ($Million) 287
Table 128 Consort Medical: Total Revenue, By Geography, 2009 – 2011 ($Million) 287
Table 129 Eli Lilly & Co: Total Revenue And R&D Expenses, 2010 – 2012 ($Billion) 298
Table 130 Eli Lilly & Co: Total Revenue, By Segment, 2010 – 2012 ($Billion) 298
Table 131 Eli Lilly & Co: Total Revenue By Geography, 2010 – 2012 ($Billion) 299
Table 132 Gerresheimer Ag: Total Revenue And R&D Expenses, 2010 – 2012 ($Million) 304
Table 133 Gerresheimer Ag: Total Revenue, By Segment, 2010 – 2012 ($Million) 304
Table 134 Gerresheimer Ag: Total Revenue, By Geography, 2010 – 2012 ($Million) 305
Table 135 Novo Nordisk: Total Revenue And R&D Expenses, 2010 – 2012 ($Billion) 317
Table 136 Novo Nordisk: Total Revenue, By Segment, 2010 – 2012 ($Billion) 317
Table 137 Novo Nordisk: Total Revenue, By Geography, 2010 – 2012 ($Billion) 318
Table 138 Sanofi: Total Revenue & R&D Expenditure, 2010 – 2012 ($Billion) 326
Table 139 Sanofi: Total Revenue, By Segment, 2010 – 2012 ($Billion) 326
Table 140 Sanofi: Total Revenue, By Geography, 2010 – 2012 ($Billion) 327
Table 141 Schott Ag: Total Revenue And R&D Expenditures, 2010 – 2012 ($Million) 331
Table 142 Schott Ag: Total Revenue, By Geography, 2010 – 2012 ($Million) 331
Table 143 Terumo Corporation: Total Revenue And R&D Expenses, 2009 – 2011 ($Million) 340
Table 144 Terumo Corporation: Total Revenue, By Segment, 2009 – 2011 ($Million) 340
Table 145 Terumo Corporation: Total Revenue, By Geography, 2009 – 2011 ($Million) 341
Table 146 Unilife Corporation: Total Revenue And R&D Expenditure, 2010 – 2012 ($Million) 346
Table 147 Unilife Corporation: Total Revenue, By Geography, 2010 – 2012 ($Million) 346
Table 148 West Pharma: Total Revenues And R&D Expenses, 2010 – 2012 ($Million) 354
Table 149 West Pharma: Total Revenue, By Segment, 2010 – 2012 ($Million) 354
Table 150 West Pharma: Total Revenue, By Geography, 2009 – 2012 ($Million) 355
Table 151 Ypsomed: Total Revenue And R&D Expenses, 2009 – 2011 ($Million) 359
Table 152 Ypsomed: Total Revenue, By Segment, 2009 – 2011 ($Million) 359
Table 153 Ypsomed: Total Revenue, By Geography, 2009 ($Million) 360
Table 154 Ypsomed: Total Revenue, By Geography, 2010 – 2011 ($Million) 360
Table 155 Zogenix, Inc.: Total Revenue And R&D Expenditure, 2010 – 2012 ($Million) 366

List Of Figures

Figure 1 Global Injectable Drug Delivery Technologies Market, By Segment, 2012 & 2017 36
Figure 2 Injectable Drug Delivery Technologies Market, By Geography, 2012 38
Figure 3 Injectable Drug Delivery Technologies Market Segmentation 41
Figure 4 Injectable Drug Delivery Technologies Market Segmentation 45
Figure 5 Market Segmentation Of Injectable Drug Delivery Technologies, By Therapeutic Application 47
Figure 6 Injectable Drug Delivery Technologies Market Dynamics 48
Figure 7 Global Conventional Injection Devices Market, By Key Players, 2012 ($Million) 59
Figure 8 Global Self-Injection Devices Market, By Key Players, 2012 ($Million) 61
Figure 9 Global Needle Free Injector Market, By Key Players, 2012 ($Million) 63
Figure 10 Global Auto Injector Market, By Key Players, 2012 ($Million) 65
Figure 11 Global Pen Injector Market, By Key Players, 2012 ($Million) 66
Figure 12 Injectable Drug Delivery Devices Technologies Market Segmentation 72
Figure 13 Factors Affecting Selection Of An Injectable Device 74
Figure 14 Global Self-Injection Devices Market, By Product, 2010 – 2017 ($Billion) 93
Figure 15 Self-Injection Devices Market Segmentation 94
Figure 16 Factors Affecting Selection Of Self-Injection Device 95
Figure 17 Conventional Drug Delivery Formulation Technologies Market Segmentation 143
Figure 18 Global Novel Drug Delivey Formulation Market, 2012 & 2017 ($Billion) 150
Figure 19 Novel Drug Delivery Formulation Technologies Segmentation 152
Figure 20 Global Injectable Drug Delivery Technologies Market, By Therapeutic Application, 2010 – 2017 ($Billion) 166
Figure 21 Injectable Drug Delivery Technologies Market Segmentation, By Therapeutic Applications 167
Figure 22 Auto-Immune Therapeutic Market Segmentation 168
Figure 23 Hormonal Disorders Market Segmentation 179
Figure 24 Injectable Drug Delivery Technologies Market, By Geography, 2012 – 2017 ($Billion) 209
Figure 25 Key GRoWth Strategies, 2010 – 2013 229
Figure 26 Key Players Focusing On Expansion, 2010 – 2013 230
Figure 27 Key Players Focusing On Agreements, Partnerships, Collaborations And Joint Ventures, 2010 – 2013 231

  • Water Treatment Chemicals Market to be driven by Increasing Demand from Developing Economies
    The global market for water treatment chemicals is growing at a steady pace with rapid urbanization and high demand from end-users. Water treatment chemicals are used for treating municipal water as well as agricultural wastewater. With higher demand for clean, drinking water with increasing population and increase in the number of industries, the global market [...]
  • Rise in Prevalence of Allergic Diseases Driving the Global Allergy Diagnostics Market
    With rise in the incidences of allergic diseases in the world, the global allergy diagnostics market has also witnessed steady growth. In recent years, there has been an increase in the number of people suffering from different allergies, particularly food allergies and drug allergies. The number of people suffering from asthma has also increased in [...]
  • Global Video Surveillance Market Driven by Increasing Demand for Security
    The global market for video surveillance has been witnessing steady growth with increase in demand for advanced surveillance systems by different law enforcement agencies. Increase in adoption of video surveillance by different sectors such as banking and finance, healthcare, transportation, and retail is one of the major drivers in the market. In 2013, the global [...]
  • Global Empty Capsules Market Driven by Growth in Pharmaceutical Industry
    With rapid growth in the pharmaceutical industry, the market for empty capsules has also grown at a steady pace. Some of the factors which are driving the growth of the empty capsules market are rise in aging population which is increasing the demand for capsule based drugs, technological advancement and increase in demand from the [...]
  • Global Aramid Fiber Industry to Witness High Growth in the Future
    With increasing use of aramid fibers in various industries, the global market for aramid fibers has grown significantly in recent years. Aramid fibers have a number of properties such as low density, heat resistance, high tensile strength, abrasion resistance, chemical resistance and impact resistance.  Asia-Pacific is the largest market for aramid fibers, followed by North [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Global Transdermal Drug Delivery Market 2014-2018
    Published: 30-Jun-2014        Price: US $2500 Onwards        Pages: 76
    Transdermal drug delivery is a large and growing vertical market of the Pharmaceutical industry. Transdermal drug delivery is defined as a system that utilizes skin as a site for continuous drug administration into the systemic circulation. Several methods of transdermal drug delivery include plasters, various ointments and, most commonly, patches. Transdermal drug administration has several advantages. First, the method of delivery is non-invasive, which is much less traumatic to the patient as......
  • Drug Delivery System Markets in China
    Published: 22-May-2014        Price: US $4000 Onwards        Pages: 218
    China's demand for Drug Delivery System has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled......
  • Global RNAi Drug Delivery Market 2014-2018
    Published: 17-Jan-2014        Price: US $2000 Onwards        Pages: 45
    TechNavio's analysts forecast the Global RNAi Drug Delivery market to grow at a CAGR of 21.80 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in RNA therapeutic development. The Global RNAi Drug Delivery market has also been witnessing some key technological advancements. However, the targeted delivery of RNA molecules is expected to pose a challenge to the growth of this market. TechNavio's report, the Global RNAi Drug Delivery Mar......
  • North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) – Forecasts To 2017
    Published: 12-Jul-2013        Price: US $4650 Onwards        Pages: 267
    Patent expiry of major blockbuster drugs is a prime concern for pharmaceutical companies, as developing a new chemical entity (NCE) is more expensive and time consuming than a novel drug delivery technology. Therefore, in recent years, several pharmaceutical companies have employed drug delivery technology as a life cycle management tool for some of their blockbuster drugs, the patents for which are set to expire in the near future. The North American drug delivery market was estimated to be ......
  • European Injectable Drug Delivery Market By Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017
    Published: 5-Jul-2013        Price: US $4650 Onwards        Pages: 333
    The European injectable drug delivery technologies market was valued at $6.8 billion in 2012, and is expected to reach $12.4 billion by 2017 at a CAGR of 12.7% from 2012 to 2017. Injectable drug delivery technologies are a combination of two major segments - devices and formulations. The European injectable drug delivery formulations technologies market is the largest segment in the market. This is due to a surge of biologics and development of nanotechnologies. In addition, the market is segmen......
  • Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies
    Published: 15-Jun-2013        Price: US $2500 Onwards        Pages: 123
    There are more than 1400 sustained or controlled release drugs approved all over the world. Revenues within the global generics market reached an estimated value of $265 b in 2012, showing a growth of 9.3% throughout the year. The contribution of generics is approximately 20% of the overall international pharmaceutical market. Utilization of generic in terms of volume is higher in the US and lower in Japan, 89% and 24% respectively. The oral drug delivery market remains the largest slice of t......
  • Global Nanotechnology Drug Delivery Market 2012-2016
    Published: 12-Mar-2013        Price: US $2000 Onwards        Pages: 35
    TechNavio's analysts forecast the Global Nanotechnology Drug Delivery market to grow at a CAGR of 73.97 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R&D cost. The Global Nanotechnology Drug Delivery market has also been witnessing an increase in customer support services. However, the increasing safety concerns could pose a challenge to the growth of this market. TechNavio's report, Global Nanotechnology Drug Delivery Market 2012-......
  • Drug Delivery: Surveying the Global Competitive Landscape
    Published: 7-Mar-2013        Price: US $1040 Onwards        Pages: 702
    Drug Delivery: Surveying the global competitive landscape is a new (March 2013) richly-detailed report which examines, in depth, 106 leading and emerging specialist drug delivery companies. The report covers all major technology areas including controlled-release, nucleic acid, nano-enabled and targeted delivery. The importance of drug-delivery technology grows ever more apparent and commercial and pharma industry interest continues to build. The new biologic products which are coming to mark......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs